Cyclerion Therapeutics (CYCN) Payables (2019 - 2025)
Cyclerion Therapeutics (CYCN) has 7 years of Payables data on record, last reported at $480000.0 in Q3 2025.
- For Q3 2025, Payables rose 57.89% year-over-year to $480000.0; the TTM value through Sep 2025 reached $480000.0, up 57.89%, while the annual FY2024 figure was $390000.0, 67.45% down from the prior year.
- Payables reached $480000.0 in Q3 2025 per CYCN's latest filing, up from $462000.0 in the prior quarter.
- Across five years, Payables topped out at $4.9 million in Q2 2021 and bottomed at $304000.0 in Q3 2024.
- Average Payables over 5 years is $2.0 million, with a median of $1.6 million recorded in 2022.
- Peak YoY movement for Payables: soared 214.7% in 2021, then plummeted 81.12% in 2024.
- A 5-year view of Payables shows it stood at $1.8 million in 2021, then surged by 62.47% to $3.0 million in 2022, then tumbled by 59.66% to $1.2 million in 2023, then crashed by 67.45% to $390000.0 in 2024, then rose by 23.08% to $480000.0 in 2025.
- Per Business Quant database, its latest 3 readings for Payables were $480000.0 in Q3 2025, $462000.0 in Q2 2025, and $483000.0 in Q1 2025.